Recipient of federal assistance · NEW YORK, NY

TRAVERSE BIOTECH II INC

TRAVERSE BIOTECH II INC received $399.9K in federal grants and other assistance in FY2026, on 2 actions, +34% vs FY2025. It has no federal contracts in the loaded years. Since FY2023: $1.4M. Its largest awarding agency was National Institutes of Health ($399.9K).

Assistance · FY2026
$399.9K
New awards
1
Actions
2
Since FY2023
$1.4M
UEI
JJUSGRQS7RM5
Location
NEW YORK, NY
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 400KFY2023
  2. 298.9KFY2024
  3. 297.7KFY2025
  4. 399.9KFY2026

By type

  1. Grants$399.9K100%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.395 · Cancer Treatment Research$399.9K100%

Awarding agencies

  1. National Institutes of Health$399.9K100%
    Department of Health and Human Services

Largest awards

  1. ORALLY AVAILABLE NOD2 AGONIST, HPX-612, FOR THE TREATMENT OF VISCERAL LEISHMANIASIS - PROJECT SUMMARY WE ARE DEVELOPING THE FIRST ORALLY…$596.7K
    93.855 · Allergy and Infectious Diseases Research· National Institutes of Health· Project grant· Apr 29, 2024 – Apr 16, 2026· R43AI181294
  2. DEVELOPMENT OF A UPAR-TARGETING ANTIBODY-DRUG CONJUGATE (ADC) FOR PANCREATIC ADENOCARCINOMA - PROJECT SUMMARY TRAVERSE BIOTECH IS…$399.9K
    93.395 · Cancer Treatment Research· National Institutes of Health· Project grant· Aug 26, 2026 – Aug 26, 2026· R43CA309866

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 10, 2026, loaded Oct 10, 2026 · FY2023–FY2026.